Nikolay Mehterov

Nikolay Mehterov serves as Associate Professor at the Department of Medical Biology, Medical University of Plovdiv, where he trains students in both Bulgarian and English language programs and acts as scientific consultant for PhD candidates. His work is anchored in the Integrative and Creative Research Division's Molecular and Regenerative Medicine group within the university's Research Institute.

Education:

• Bachelor's degree in Biology, Plovdiv University "Paisiy Hilendarski"
• Master's degree in Molecular Biology and Biotechnology, Plovdiv University "Paisiy Hilendarski"
• Doctor of Molecular Biology, Plovdiv University "Paisiy Hilendarski"

Dr. Mehterov's research centers on miRNA mechanisms in head and neck tumors, specializing in novel miRNA identification, target mRNA prediction, and functional validation using tumor-derived cell lines. His work bridges molecular oncology, regenerative medicine, and translational cancer research, with international specialization across Switzerland, Netherlands, Germany, Romania, and Italy. The research directly supports the university's Molecular and Regenerative Medicine division while contributing to broader initiatives in innovative diagnostics and patient safety.

With over 30 Scopus and Web of Science-indexed publications, his scholarly output demonstrates consistent focus on molecular pathways in head and neck oncology, particularly miRNA regulatory networks with potential diagnostic and therapeutic applications in cancer treatment and tissue regeneration.

Dr. Mehterov actively shapes medical education through co-authorship of essential study materials for medical, dental, and pharmacy students while mentoring doctoral researchers. His international training background enriches the curriculum with cross-border scientific perspectives.

Based in the Department of Medical Biology, he operates within the Research Institute's Integrative and Creative Research Division, specifically contributing to the Molecular and Regenerative Medicine team alongside parallel initiatives in translational neuroscience, pharmaceutical innovations, and environmental health.